Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

About Sunesis Pharmaceuticals

Sunesis Pharmaceuticals logoSunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia (AML). Vosaroxin is an anticancer quinolone derivative (AQD). The Company's other kinase inhibitor pipeline include TAK-580, SNS-062 and SNS-229. TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors. SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). The Company has completed the pre-clinical studies for SNS-062. SNS-229 and SNS-510 are two PDK1 inhibitors. PDK1 is a kinase and mediator of Phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling, which is a pathway involved in cell growth, differentiation, survival and migration.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SNSS
  • CUSIP: 86732860
Key Metrics:
  • Previous Close: $4.44
  • 50 Day Moving Average: $4.49
  • 200 Day Moving Average: $3.55
  • 52-Week Range: $14,502,000.00 - $2.64
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.07
  • P/E Growth: -0.01
  • Market Cap: $64.39M
  • Outstanding Shares: 14,502,000
  • Beta: 1.77
Profitability:
  • Net Margins: -1,503.34%
  • Return on Equity: -806.43%
  • Return on Assets: -102.31%
Debt:
  • Current Ratio: 3.26%
  • Quick Ratio: 3.26%
Additional Links:
Companies Related to Sunesis Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Sunesis Pharmaceuticals (NASDAQ:SNSS) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: N/A

Analysts' Ratings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Show:
DateFirmActionRatingPrice TargetDetails
9/12/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
9/12/2016Cowen and CompanyReiterated RatingHoldView Rating Details
7/29/2016Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details
7/24/2015Roth CapitalDowngradeBuy -> Sell$5.50 -> $1.00View Rating Details
7/2/2015WedbushReiterated RatingHold$2.00View Rating Details
1/6/2015BTIG ResearchInitiated CoverageBuy$5.50View Rating Details
10/6/2014Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$9.00 -> $3.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
7/29/2016Q216($0.10)($0.12)$0.70 million$0.60 millionViewListenView Earnings Details
5/5/2016Q116($0.12)($0.12)$0.77 million$0.64 millionViewListenView Earnings Details
3/10/2016Q415($0.14)($0.15)$0.84 million$0.67 millionViewListenView Earnings Details
11/5/2015Q315($0.12)($0.09)$1.09 million$0.68 millionViewListenView Earnings Details
7/30/2015Q215($0.13)($0.15)$1.21 million$0.85 millionViewN/AView Earnings Details
5/5/2015Q115($0.16)($0.13)$1.14 million$0.90 millionViewListenView Earnings Details
3/12/2015Q414($0.20)($0.02)$1.17 million$0.90 millionViewListenView Earnings Details
11/10/2014Q314($0.17)($0.25)$1.97 million$0.85 millionViewListenView Earnings Details
8/5/2014Q214($0.17)($0.20)$1.32 million$2.00 millionViewListenView Earnings Details
5/7/2014Q114($0.17)($0.26)$1.32 million$2.00 millionViewListenView Earnings Details
3/6/2014Q413($0.20)($0.15)$1.37 million$2.00 millionViewListenView Earnings Details
11/12/2013Q313($0.20)($0.16)$1.44 million$1.99 millionViewListenView Earnings Details
7/29/2013Q2 2013($0.21)$0.18$1.22 million$1.99 millionViewListenView Earnings Details
5/9/2013Q1 2013($0.20)($0.23)$0.75 million$1.99 millionViewListenView Earnings Details
3/13/2013Q4 2012($0.19)($0.20)$0.32 million$1.99 millionViewListenView Earnings Details
11/8/2012Q312($0.11)($0.37)$4.17 million$0.26 millionViewN/AView Earnings Details
8/9/2012($0.20)($0.20)ViewN/AView Earnings Details
5/15/2012($0.18)($0.30)ViewN/AView Earnings Details
11/14/2011($0.18)($0.11)ViewN/AView Earnings Details
8/11/2011($0.15)($0.18)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Current Year EPS Consensus Estimate: $-2.63 EPS
Next Year EPS Consensus Estimate: $-2.15 EPS

Dividends

Dividend History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Insider Ownership Percentage: 14.05%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2016Geoffrey M ParkerDirectorBuy9,500$0.47$4,465.00View SEC Filing  
5/25/2016Geoffrey M ParkerDirectorBuy52,505$0.47$24,677.35View SEC Filing  
12/21/2015Dayton MisfeldtDirectorBuy1,750,000$0.84$1,470,000.00View SEC Filing  
8/25/2015Daniel N Swisher JrCEOBuy12,216$1.01$12,338.16View SEC Filing  
8/24/2015Daniel N Swisher JrCEOBuy12,784$1.01$12,911.84View SEC Filing  
8/29/2014Forest BaskettMajor ShareholderSell266,700$7.97$2,125,599.00View SEC Filing  
8/28/2014Bay City Capital LlcMajor ShareholderSell300,700$7.98$2,399,586.00View SEC Filing  
8/28/2014Dayton MisfeldtDirectorSell200,000$7.89$1,578,000.00View SEC Filing  
8/27/2014Adam R CraigCMOSell2,554$8.00$20,432.00View SEC Filing  
8/27/2014Daniel N Swisher JrCEOSell5,000$8.00$40,000.00View SEC Filing  
8/27/2014Dayton MisfeldtDirectorSell100,700$8.16$821,712.00View SEC Filing  
8/27/2014Eric BjerkholtCFOSell10,000$8.00$80,000.00View SEC Filing  
8/27/2014Krishna Kittu KolluriMajor ShareholderSell108,300$8.17$884,811.00View SEC Filing  
8/12/2014Dayton MisfeldtDirectorSell743,700$6.64$4,938,168.00View SEC Filing  
8/12/2014Equity Opportunities Fu GrowthMajor ShareholderSell710,540$6.63$4,710,880.20View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sunesis Pharmaceuticals (NASDAQ:SNSS)
DateHeadline
4-traders.com logoSunesis Pharmaceuticals : Announces 1-for-6 Reverse Stock Split (NASDAQ:SNSS)
www.4-traders.com - September 25 at 12:40 PM
4-traders.com logoSunesis Pharmaceuticals : to Present at Upcoming Investor Conferences (NASDAQ:SNSS)
www.4-traders.com - September 24 at 11:43 AM
News IconWhat are Research Firms Saying About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? - Frisco Fastball (NASDAQ:SNSS)
friscofastball.com - September 19 at 11:55 AM
biz.yahoo.com logoSUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:SNSS)
biz.yahoo.com - September 12 at 6:55 PM
publicnow.com logoSunesis Presents Dose Escalation Results from the Phase 1A Healthy Volunteer Study Evaluating Oral Non-Covalent BTK inhibitor SNS-062 (NASDAQ:SNSS)
www.publicnow.com - September 12 at 12:05 PM
biz.yahoo.com logoSunesis Pharmaceuticals, Inc. Preliminary Results From the Oral Non-Covalent BTK-inhibitor SNS-062 Call scheduled for 8:00 am ET today (NASDAQ:SNSS)
biz.yahoo.com - September 12 at 12:05 PM
News IconStock Stepping Up to a Recent High: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Post News (NASDAQ:SNSS)
www.kentuckypostnews.com - September 9 at 6:59 PM
News IconWhat are Analysts Expecting for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Earnings? - Frisco Fastball (NASDAQ:SNSS)
friscofastball.com - September 9 at 6:59 PM
capitalcube.com logoETF’s with exposure to Sunesis Pharmaceuticals, Inc. : September 9, 2016 (NASDAQ:SNSS)
www.capitalcube.com - September 9 at 12:09 PM
News IconBiotech Stocks Worth Chasing: Sunesis Pharmaceuticals, Inc ... - The Independent Republic (NASDAQ:SNSS)
theindependentrepublic.com - September 8 at 7:02 PM
globenewswire.com logoSunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split - GlobeNewswire (press release) (NASDAQ:SNSS)
www.globenewswire.com - September 8 at 7:02 PM
streetinsider.com logoSunesis Pharmaceuticals (SNSS) Files for One-for-Six Reverse Stock Split - StreetInsider.com (NASDAQ:SNSS)
www.streetinsider.com - September 7 at 7:30 PM
publicnow.com logoSunesis Pharmaceuticals Announces 1-for-6 Reverse Stock Split (NASDAQ:SNSS)
www.publicnow.com - September 7 at 7:30 PM
biz.yahoo.com logoSUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fina (NASDAQ:SNSS)
biz.yahoo.com - September 7 at 7:30 PM
streetinsider.com logoSunesis Pharmaceuticals (SNSS) Announces Presentation of SNS-062 Phase 1a Data (NASDAQ:SNSS)
www.streetinsider.com - September 1 at 7:20 PM
streetinsider.com logoSunesis Pharmaceuticals (SNSS) Announces Presentation of SNS-062 Phase 1a Data - StreetInsider.com (NASDAQ:SNSS)
www.streetinsider.com - September 1 at 10:36 AM
publicnow.com logoSunesis Pharmaceuticals Announces Poster Presentation on Preliminary Results from the Phase 1A Healthy Volunteer Study Evaluating Oral Non-Covalent BTK-inhibitor SNS-062 at the European School of Haematology’s 2nd International Conference o (NASDAQ:SNSS)
www.publicnow.com - September 1 at 10:36 AM
publicnow.com logoSunesis to Present at Upcoming Investor Conferences (NASDAQ:SNSS)
www.publicnow.com - August 31 at 12:47 PM
News Icon$ESV & $SNSS - ENSCO PLC (NYSE:ESV) & Sunesis Pharmaceuticals, (NASDAQ:SNSS) Intraday Movers - Money News (press release) (NASDAQ:SNSS)
www.newsismoney.com - August 29 at 7:19 PM
publicnow.com logoSunesis Announces Publication in "Drugs" Detailing Molecular and Pharmacologic Properties of Vosaroxin (NASDAQ:SNSS)
www.publicnow.com - August 25 at 12:35 PM
investornewswire.com logoWill Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Hit $2.5 Price Target? - Investor Newswire (NASDAQ:SNSS)
www.investornewswire.com - August 19 at 10:25 AM
News IconSunesis Pharmaceuticals, Inc.'s (SNSS): Stock's Report of the Thursday - Hot Stocks Point (NASDAQ:SNSS)
www.hotstockspoint.com - August 19 at 10:25 AM
capitalcube.com logoETF’s with exposure to Sunesis Pharmaceuticals, Inc. : August 18, 2016 (NASDAQ:SNSS)
www.capitalcube.com - August 18 at 7:45 PM
News IconTrading the Biotech News: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), ContraVir Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:SNSS)
voiceregistrar.com - August 18 at 10:35 AM
finance.yahoo.com logoSunesis Pharmaceuticals (SNSS) Jumps: Stock Rises 23.1% (NASDAQ:SNSS)
finance.yahoo.com - August 18 at 10:35 AM
finance.yahoo.com logoSUNESIS PHARMACEUTICALS INC Financials (NASDAQ:SNSS)
finance.yahoo.com - August 5 at 7:44 PM
capitalcube.com logoETF’s with exposure to Sunesis Pharmaceuticals, Inc. : August 4, 2016 (NASDAQ:SNSS)
www.capitalcube.com - August 4 at 7:58 PM
capitalcube.com logoSunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:SNSS)
www.capitalcube.com - August 3 at 7:53 PM
News IconUpbeat Biotech Stocks- Sunesis Pharmaceuticals (NASDAQ:SNSS), CytRx Corporation (NASDAQ:CYTR) - Seneca Globe (NASDAQ:SNSS)
www.senecaglobe.com - August 2 at 12:28 PM
News IconTechnical Evaluation For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - The Voice Registrar (NASDAQ:SNSS)
voiceregistrar.com - August 2 at 12:28 PM
News IconDoes Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) Have Sufficient Cash To Remain Afloat? - Scibility Media (NASDAQ:SNSS)
scibilitymedia.com - August 2 at 12:28 PM
equities.com logoSunesis Pharmaceuticals Inc. (SNSS) Jumps 7.56% on August 01 - Equities.com (NASDAQ:SNSS)
www.equities.com - August 1 at 7:17 PM
finance.yahoo.com logoEdited Transcript of SNSS earnings conference call or presentation 29-Jul-16 3:00pm GMT (NASDAQ:SNSS)
finance.yahoo.com - August 1 at 7:16 PM
News IconBeatable Stocks in Active Notes- Alphabet (NASDAQ:GOOG), Sunesis Pharmaceuticals (NASDAQ:SNSS), Wellesley ... - Seneca Globe (NASDAQ:SNSS)
www.senecaglobe.com - August 1 at 12:08 PM
News IconHC Stocks Newsbeat: Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - share market updates (press release) (NASDAQ:SNSS)
sharemarketupdates.com - August 1 at 12:08 PM
istreetwire.com logoTraders Recap: Sunesis Pharmaceuticals, Inc. (SNSS), CSX Corp. (CSX), Eclipse Resources Corporation (ECR) - iStreetWire (NASDAQ:SNSS)
istreetwire.com - August 1 at 12:08 PM
News IconUnited Parcel Service, (NYSE:UPS) & Sunesis Pharmaceuticals, (NASDAQ:SNSS) Stock's Buzzers - Money News (press release) (NASDAQ:SNSS)
www.newsismoney.com - August 1 at 12:08 PM
smarteranalyst.com logoCowen Comments on Sunesis Pharmaceuticals, Inc. (SNSS) Following 2Q:16 Update - Smarter Analyst (NASDAQ:SNSS)
www.smarteranalyst.com - July 31 at 11:20 AM
equities.com logoSunesis Pharmaceuticals Inc. (SNSS) Jumps 28.44% on July 29 - Equities.com (NASDAQ:SNSS)
www.equities.com - July 30 at 10:14 AM
finance.yahoo.com logo7:04 am Sunesis Pharma misses by $0.02, misses on revs (NASDAQ:SNSS)
finance.yahoo.com - July 30 at 7:04 AM
twst.com logoSunesis Pharmaceuticals Inc.: Sunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Highlights (NASDAQ:SNSS)
www.twst.com - July 29 at 7:41 PM
nasdaq.com logoSunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Highlights (NASDAQ:SNSS)
www.nasdaq.com - July 29 at 10:35 AM
4-traders.com logoSunesis Pharmaceuticals : reports 2Q loss (NASDAQ:SNSS)
www.4-traders.com - July 29 at 10:35 AM
sg.finance.yahoo.com logoSunesis reports 2Q loss (NASDAQ:SNSS)
sg.finance.yahoo.com - July 29 at 9:18 AM
News IconStock Moving Lower for the Month; Investor Update on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Engelwood Daily (NASDAQ:SNSS)
www.engelwooddaily.com - July 22 at 10:24 AM
News IconSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:SNSS)
www.engelwooddaily.com - July 22 at 10:24 AM
investornewswire.com logoIs $2.5 Price Target Attainable For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? - Investor Newswire (NASDAQ:SNSS)
www.investornewswire.com - July 22 at 10:24 AM
News IconEquity Roundup: Stock Performance Focus on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Press Telegraph (NASDAQ:SNSS)
presstelegraph.com - July 22 at 10:24 AM
news.cmlviz.com logoSunesis Pharmaceuticals Inc (NASDAQ:SNSS) Stock Technicals at Critical Inflection Point - CML News (NASDAQ:SNSS)
news.cmlviz.com - July 22 at 10:24 AM
News IconInsiders Increasing Positions in: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Press Telegraph (NASDAQ:SNSS)
presstelegraph.com - July 21 at 10:19 AM

Social

Sunesis Pharmaceuticals (NASDAQ:SNSS) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff